Skye bioscience inc

0.00 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Skye bioscience inc stock is down -100% since 30 days ago. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 9 February’s closed higher than January. 100% of analysts rate it a buy.

About Skye bioscience inc

Skye Bioscience, Inc. discovers, develops, and commercializes cannabinoid-based molecules. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension.